Non-infectious posterior uveitis is a chronic inflammatory eye disease that can lead to irreversible retinal damage and visual impairment due to repeated inflammatory relapses.
The fluocinolone acetonide intravitreal implant is approved for the prevention of inflammatory relapses in this condition, but data from real-world clinical practice remain limited, particularly regarding the intensity of relapses over time.
This multicenter retrospective observational study aims to evaluate the frequency and intensity of inflammatory recurrences in adult patients with non-infectious posterior uveitis treated with a fluocinolone acetonide implant. Clinical and imaging data routinely collected during follow-up will be analyzed over a three-year period to better characterize long-term outcomes, treatment burden, and safety in real-life conditions.
Adult patients aged 18 years or older
Diagnosis of non-infectious uveitis with posterior segment involvement
Presence of uveitic macular edema or persistent posterior segment inflammation
Treatment with a fluocinolone acetonide intravitreal implant prior to January 2024
Infectious uveitis
Refusal to participate or documented opposition to the study
Follow-up duration shorter than 12 months after implantation